量化美国与相关的心血管疾病负担
Farah Abdulhai1, Issam Motairek1, Saeid Mirzai2
1Internal medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Current problems in cardiology
|April 10, 2024
概括
在1990年至2019年期间,暴露在美国显著降低了超过60%的心血管疾病死亡率和残疾率. 这项研究强调了减少的进展.
科学领域:
- 环境健康 环境健康
- 心血管疾病流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 暴露是各种心血管疾病 (CVD) 的已知危险因素.
- 了解与接触有关的心血管疾病负担的趋势对于公共卫生至关重要.
- 以前的研究表明,与心血管不良结果之间存在联系.
研究的目的:
- 量化1990年至2019年美国因暴露导致的年龄标准化心血管疾病死亡率和残疾调整寿命年 (DALYs) 的趋势.
- 评估减少暴露对心血管健康结果的影响.
- 提供有关对心脏病负担的贡献的最新流行病学数据.
主要方法:
- 利用了2019年全球疾病负担研究的数据.
- 分析了与心血管疾病的暴露相关的年龄标准化死亡率和DALY.
- 美国1990年至2019年间暴露导致的心血管疾病死亡率和DALY的计算百分比变化.
主要成果:
- 导致暴露的年龄标准化心血管疾病死亡率减少了60% (从每10万人的7.4到2.9).
- 由于暴露于而导致的年龄标准化心血管疾病DALY减少了66% (从每10万人中143.2人降至48.7人).
- 三十年来,与相关的心血管疾病负担的显著下降.
结论:
- 作为美国心血管疾病死亡率和残疾的原因,暴露已大幅减少.
- 减少暴露的公共卫生努力可能有助于这些积极的趋势.
- 持续监测和预防策略至关重要,以进一步减少对心血管健康的影响.
更多相关视频
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.9K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
01:23Assessment of the Cardiovascular System I: Subjective Data
323
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
323
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81